Paragon Care WKN: A0Q4D2 ISIN: AU000000PGC4 Kürzel: PXS Branche: Gesundheit, Medizinischer, Vertrieb

PARAGON CARE Aktie • Kurs heute
0,1855 EUR
+6,92 %+0,0120
28. Mär, 22:59:15 Uhr, L&S Exchange
Marktkapitalisierung 122,3 Mio. EUR
KGV 26,03
Ergebnis je Aktie 0,01 EUR
k.A. % HL Intervall: k.A. High: k.A. Low: k.A. Börse: k.A.
k.A. % HL Intervall: k.A. High: k.A. Low: k.A. Börse: k.A.
k.A. % HL Intervall: k.A. High: k.A. Low: k.A. Börse: k.A.
k.A. % HL Intervall: k.A. High: k.A. Low: k.A. Börse: k.A.
k.A. % HL Intervall: k.A. High: k.A. Low: k.A. Börse: k.A.
k.A. % HL Intervall: k.A. High: k.A. Low: k.A. Börse: k.A.
k.A. % HL Intervall: k.A. High: k.A. Low: k.A. Börse: k.A.
k.A. % HL Intervall: k.A. High: k.A. Low: k.A. Börse: k.A.
Anzeige
Smartbroker entdecken
Jetzt Smartbroker
Smartbrokerplus
Schreib den ersten Kommentar!
Kursdetails
Geld (bid) 0,1720 (2.882)
Brief (ask/offer) 0,1990 (2.882)
Spread 13,5678
Geh. Stück 0
Eröffnung 0,1735
Vortag 0,1735
Tageshoch 0,1855
Tagestief 0,1735
52W Hoch 0,1860
52W Tief 0,0910
Tagesvolumen
in EUR gehandelt 0 Stk
in AUD gehandelt 0 Stk
Gesamt 0 Stk
Partner-News
Anzeige

7:01 Uhr • Partner • Societe Generale

Gestern 18:00 Uhr • Partner • Societe Generale

Gestern 16:46 Uhr • Partner • Societe Generale

Gestern 16:00 Uhr • Partner • BNP Paribas

Gestern 15:00 Uhr • Partner • HSBC

Aktien-News

11:53 Uhr • Partner • Finanztrends

Anzeige

11:53 Uhr • Meldungen • EQS News

11:38 Uhr • Partner • MediaFeed

11:30 Uhr • Meldungen • EQS News

11:30 Uhr • Meldungen • EQS News

Geld/Brief Kurse
Neu laden
Börse Geld Vol. Brief Vol. Zeit Vol. ges. Kurs
L&S Exchange 0,1720 2.882 Stk 0,1990 2.882 Stk 1711663155 28. Mar 0,1855 EUR
Frankfurt 0,1720 12.281 Stk 0,2000 20.000 Stk 1711609546 28. Mar 0,1720 EUR
Tradegate 0,1720 5.000 Stk 0,1990 5.000 Stk 1711661181 28. Mar 0,1860 EUR
Lang & Schwarz 0,1720 2.882 Stk 0,1990 2.882 Stk 1711663126 28. Mar 0,1855 EUR
TTMzero RT 1711630267 28. Mar 0,1855 EUR
Stuttgart 0,1720 4.444 Stk 0,1990 4.444 Stk 1711618475 28. Mar 0,1710 EUR
Sydney 1711429838 26. Mar 0,2800 AUD
ges. 0 Stk
Realtime / Verzögert
Börsennotierung
Marktkapitalisierung in EUR
122,3 Mio.
Anzahl der Aktien
659,3 Mio.
Termine
28.08.2024 Quartalsmitteilung
02/25 Quartalsmitteilung
Grundlegende Daten zur PARAGON CARE Aktie
Finanzdaten 2020 2021 2022 2023 2024e 2025e 2026e
KUV 0,19 0,36 0,71 0,47 - - -
Ergebnis je Aktie (bereinigt) -0,30 0,02 0,01 0,02 0,01 - -
Cashflow 5,3 Mio. 27,5 Mio. 19,0 Mio. 17,7 Mio. - - -
Eigenkapitalquote 38,43 % 41,63 % 53,79 % 54,14 % - - -
Verschuldungsgrad 160,21 140,23 83,25 80,94 - - -
EBIT 4,1 Mio. 14,0 Mio. 21,3 Mio. 26,4 Mio. - - -
Fundamentaldaten 2020 2021 2022 2023 2024e 2025e 2026e
KCV 8,50 3,05 8,51 7,00 - - -
Dividendenrendite 2,53 % 4,32 % 4,02 % 4,07 % - - -
Kurs-Gewinn-Verhältnis (KGV) -0,57 12,21 25,52 10,50 26,03 - -
Dividende je Aktie 0,011 0,016 0,012 0,01 - - -
Bilanzdaten 2020 2021 2022 2023 2024e 2025e 2026e
Umsatzerlöse 231,7 Mio. 235,8 Mio. 237,6 Mio. 307,6 Mio. - - -
Ergebnis vor Steuern -77,2 Mio. 12,3 Mio. 9,9 Mio. 20,9 Mio. - - -
Steuern 66.000 4,1 Mio. 3,3 Mio. 10,1 Mio. - - -
Ausschüttungssumme 7,9 Mio. 7,9 Mio. 7,9 Mio. 7,9 Mio. - - -

Info PARAGON CARE Aktie

Paragon Care

Paragon Care Limited supplies durable medical equipment, medical devices, and consumable medical products to health and aged care markets in Australia, New Zealand, and internationally. The company offers clinical solutions for anaesthetists, intensivists, cardiac, vascular, and pain management; designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohaematology laboratories; and eye care products, such as ophthalmology and optometry, neonatal vision screening, and procedural kits. It also provides neonatal and paediatric assessment and treatment, including newborn hearing and vision screening, jaundice management, targeted temperature management, cerebral function monitoring, and seizure detection, as well as pain management and enteral feeding solutions; surgical products for hip and knee arthroplasty, infection prevention, pain management, biologics, and the operating room; and equipment repair and maintenance services. In addition, the company offers sterilisable transducers for surgical procedures such as neurology, hepatobiliary, renal, colorectal, vascular, laparoscopic, and robotic procedures; ultrasound systems, shockwave therapy, lasers, and accessories for infection control; and veterinary products, including point-of-care diagnostics, therapeutic lasers, oncology delivery products, centrifuges, autoclaves, IV lines and fluid therapy products, wearable CRI systems, and IT Solutions. Further, it provides telephony, nurse call, access control, CCTV, cordless, and Wi-Fi products. The company was formerly known as Citrofresh International Limited and changed its name to Paragon Care Limited in June 2008. The company was incorporated in 1994 and is based in Mt Waverley, Australia.